Cancer Research Technology
Log in Register
Menu

 

71 results

 

Q: Who is Ximbio for?

A:
Ximbio is designed and developed to support researchers and technology transfer offices, bench scientists, life science companies and the life sciences community in general. Read more

Q: Does my Indication of choice need to be related to cancer?

A:
No – Collaborative Toolkit welcomes all rational research proposals for validation of targets in any indication.

Q: What is the Collaborative Toolkit?

A:
The Collaborative Toolkit is a facility which has been created to maximise the impact of drug discovery projects via collaboration. We want to accelerate target validation research into minimally-understood cancer drug targets. Read more
Page 1 of 8